SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 190.43-0.7%Feb 6 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gottfried who wrote (486)1/9/1997 9:44:00 AM
From: Henry Niman   of 32384
 
Gottfried, I think LGND's price in January will be a re-run, but
there will be much more news. I you look at LGND's site
prnewswire.com which has 1 year's
worth of press releases, you will say that they only news for 1Q
was the H&Q presentation (press releases on Targretin and Panretin
for topical KS) and the expanded AHP agreement on progestins.
That's it (the next press release is the end of March on finacials).
Reuters has already predicted a leptin deal this month and LGND will
begin phase II trails on type II diabetes this quarter. However, much
more is happeneing on the clinical front (30 on-going trials and more
planned for ALRT1550) and more brokers have LGND at a STRONG BUY
(4 of the 5 recs). LGND moved up 38% in 1996. I expect 1997 to be
much better.

Henry
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext